Who owns the EVOX THERAPEUTICS trademark?

The EVOX THERAPEUTICS trademark is owned by Evox Therapeutics Limited.

What is the serial number for EVOX THERAPEUTICS?

The USPTO serial number for EVOX THERAPEUTICS is 79359336.

What is the registration number for EVOX THERAPEUTICS?

EVOX THERAPEUTICS is registered under USPTO registration number 0.

EVO

USPTO Trademark Record

PENDING

EVOX THERAPEUTICS

Q: What class is the EVOX THERAPEUTICS trademark registered in?

The EVOX THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79359336·Reg 0·Filed Dec 01, 2022

Owner Evox Therapeutics Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

EVOX THERAPEUTICS (Serial No. 79359336), Registration No. 0, is a pending US trademark filed on Dec 01, 2022 by Evox Therapeutics Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

EVOX THERAPEUTICS (Reg. #0) is a pending US trademark that was filed in 2022 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 5 opposition proceedings during prosecution.

FILED

Dec 01, 2022

SERIAL

79359336

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Evox Therapeutics Limited

Entity

Not Provided

Address

Oxford Science Park,, Medawar Centre, 2nd Floor East Building, Robert Robinson Avenue Oxford, Oxfordshire OX4 4HG

Country

Attorney

NameLAURA POPP ROSENBERG

Law firm

LAURA POPP ROSENBERG FROSS ZELNICK LEHRMAN & ZISSU PC

Docket

EVOX 2509626

Address

151 WEST 42ND STREET 17TH FLOOR, NEW YORK, NY 10036, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateDec 01, 2022

Serial Number79359336

Registration No.0

Registration DateDec 31, 1969

Status DateMay 21, 2025

Published for OppositionJan 21, 2025

Mark TypeStandard characters

Attorney DocketEVOX 2509626

Status DescriptionLive and pending, opposition pending

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 5× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

REFUSAL PROCESSED BY IB

Jun 21, 2025

REFUSAL PROCESSED BY IB

OPPOSITION INSTITUTED NO. 999999

May 21, 2025

OPPOSITION INSTITUTED NO. 999999

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

May 21, 2025

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

OPPOSITION NOTICE (IB REFUSAL) CREATED

May 20, 2025

OPPOSITION NOTICE (IB REFUSAL) CREATED

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

May 20, 2025

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

EXTENSION OF TIME TO OPPOSE RECEIVED

Jan 30, 2025

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Jan 21, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 21, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 15, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXPARTE APPEAL TERMINATED

Dec 26, 2024

EXPARTE APPEAL TERMINATED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 23, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 23, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 23, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

EXPARTE APPEAL RECEIVED AT TTAB

Dec 20, 2024

EXPARTE APPEAL RECEIVED AT TTAB

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Dec 20, 2024

JURISDICTION RESTORED TO EXAMINING ATTORNEY

EX PARTE APPEAL-INSTITUTED

Dec 20, 2024

EX PARTE APPEAL-INSTITUTED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Dec 20, 2024

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Nov 25, 2024

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL REFUSAL WRITTEN

Jun 20, 2024

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jun 20, 2024

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jun 20, 2024

NOTIFICATION OF FINAL REFUSAL EMAILED

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jun 07, 2024

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

ASSIGNED TO EXAMINER

May 14, 2024

ASSIGNED TO EXAMINER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 06, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 04, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 04, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

CORRECTION CREATED FOR IB

Nov 27, 2023

CORRECTION CREATED FOR IB

CORRECTION SENT TO IB

Nov 27, 2023

CORRECTION SENT TO IB

REFUSAL PROCESSED BY IB

Oct 31, 2023

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 05, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

REFUSAL PROCESSED BY MPU

Oct 04, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 24, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 23, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 11, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jan 07, 2023

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 03, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Dec 30, 2022

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

EVOX THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Evox Therapeutics Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company